Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThis updates the ClinicalTrials.gov page’s software/UI revision indicator from v3.5.2 to v3.5.3, with no change to the study’s recorded history content shown on the page.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the study record history.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.4.3 appears in the Study Record Versions, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older government-funding notices were removed. These are administrative updates to the page history and do not affect the study record content.SummaryDifference0.9%

- Check97 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, with a link to opm.gov. The history also shows Revision: v3.4.1 added and Revision: v3.4.0 removed.SummaryDifference0.9%

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.